Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

Veeva Systems' specialization in life sciences, strong balance sheet, and innovative culture position it well for long-term ...

Geneos Wealth Management Inc. lessened its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 4.0% during ...

Fifth Third Bancorp raised its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission.

In the closing of the recent trading day, Veeva Systems (VEEV) stood at $225.77, denoting a +1.06% change from the preceding trading day.

Biopharmas use leading CTMS for improved trial efficiency and collaboration BARCELONA, Spain, Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 ...

Investing in solid companies in these fields could lead to outsized returns over the next decade and beyond. Two such growth ...

Veeva Systems Inc (VEEV) stock saw a decline, ending the day at $222.97 which represents a decrease of $-6.10 or -2.66% from the prior close of $229.07. The stock opened at $213.85 and touched a low ...

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship ...

Veeva Systems (VEEV) reachead $223.40 at the closing of the latest trading day, reflecting a +0.19% change compared to its last close.

Veeva Systems (VEEV – Research Report) received a Sell rating and price target from Goldman Sachs analyst Gabriela Borges yesterday. The ...